Assessment of Subconjunctival Delivery with Model Ionic Permeants and Magnetic Resonance Imaging-Reference-Cited by-同舟云学术

Assessment of Subconjunctival Delivery with Model Ionic Permeants and Magnetic Resonance Imaging

Published:2004-12 Issue:12 Volume:21 Page:2175-2184
ISSN:0724-8741
Container-title:Pharmaceutical Research
language:en
Short-container-title:Pharm Res

Author:

Li S. Kevin,Molokhia Sarah A.,Jeong Eun-Kee

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology

Link

http://link.springer.com/content/pdf/10.1007/s11095-004-7669-3.pdf

Reference38 articles.

1. 1. T. W. Kim, J. D. Lindsey, M. Aihara, T. L. Anthony, and R. N. Weinreb. Intraocular distribution of 70-kDa dextran after subconjunctival injection in mice. Invest. Ophthalmol. Vis. Sci. 43:1809?1816 (2002).

2. 2. Y. Yanagi, Y. Tamaki, R. Obata, K. Muranaka, N. Homma, H. Matsuoka, and H. Mano. Subconjunctival administration of bucillamine suppresses choroidal neovascularization in rat. Invest. Ophthalmol. Vis. Sci. 43:3495?3499 (2002).

3. 3. U. B. Kompella, N. Bandi, and S. P. Ayalasomayajula. Subconjunctival nano- and microparticles sustain retinal delivery of budesonide, a corticosteroid capable of inhibiting VEGF expression. Invest. Ophthalmol. Vis. Sci. 44:1192?1201 (2003).

4. 4. N. Worakul and J. R. Robinson. Ocular pharmacokinetics/pharmacodynamics. Eur. J. Pharm. Biopharm. 44:71?83 (1997).

5. 5. T. J. Zimmerman, K. S. Kooner, M. Sharir, and R. D. Fechtner. Textbook of Ocular Pharmacology, Lippincoot-Raven, Philadelphia, 1997.

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design principles of ocular drug delivery systems: importance of drug payload, release rate, and material properties;Drug Discovery Today;2019-08

2. Ocular Biodistribution Studies Using Molecular Imaging;Pharmaceutics;2019-05-16

3. RNA nanoparticle distribution and clearance in the eye after subconjunctival injection with and without thermosensitive hydrogels;Journal of Controlled Release;2018-01

4. Transscleral Iontophoretic Drug Delivery for Treating Retinal Diseases;Drug Delivery for the Retina and Posterior Segment Disease;2018

5. Transscleral passive and iontophoretic transport: theory and analysis;Expert Opinion on Drug Delivery;2017-12-05